Stein, Rhona <br/><br/>
Characterization of a humanized IgG4 anti-HLA-DR monoclonal antibody that lacks effector cell functions but retains direct antilymphoma activity and increases the potency of rituximab.  [electronic resource] 

 -  Blood  Oct 2006 
 - 2736-44 p.  digital 
<br/><br/> Publication Type: Comparative Study; Journal Article; Research Support, N.I.H., Extramural 
<br/><br/><label>ISSN: </label>0006-4971 
<br/><br/><label>Standard No.: </label>10.1182/blood-2006-04-017921  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Animals<br/>Antibodies, Monoclonal--administration & dosage<br/>Antibodies, Monoclonal, Humanized--administration & dosage<br/>Antibodies, Monoclonal, Murine-Derived<br/>Antibody-Dependent Cell Cytotoxicity<br/>Apoptosis<br/>Burkitt Lymphoma--immunology<br/>Cell Line, Tumor<br/>Cell Proliferation<br/>Complement System Proteins--metabolism<br/>Cytotoxicity, Immunologic<br/>Female<br/>HLA-DR Antigens--immunology<br/>Humans<br/>Immunoglobulin G--administration & dosage<br/>Lymphoma--immunology<br/>Lymphoma, B-Cell--immunology<br/>Mice<br/>Mice, SCID<br/>Neoplasm Transplantation<br/>Rituximab<br/>Transplantation, Heterologous